Table 2.
Changes in 12-Month Change in Quality of Life (Estimated Between-Group Differences)
| SCORE | N | ESTIMATED DIFFERENCE | 95% CONFIDENCEINTERVAL | p |
|---|---|---|---|---|
| KCCQa | ||||
| Overall summary score | 416 | 5.5 | 2.3–8.7 | <0.001 |
| Clinical summary score | 416 | 4.0 | 0.7–7.3 | 0.017 |
| WHO-5 | ||||
| Raw value | 409 | 1.3 | 0.3–2.3 | 0.010 |
| Percentage value | 409 | 5.0 | 1.2–8.9 | 0.010 |
| SF-36 | ||||
| Physical component | 412 | 2.0 | 0.5–3.5 | 0.009 |
| Mental component | 412 | 2.7 | 0.9–4.6 | 0.004 |
a
Overall summary score includes the total symptom, physical function, social limitations and quality-of-life scores. Clinical Summary Score includes total symptom and physical function scores.
KCCQ, Kansas City Cardiomyopathy Questionnaire; SF-36, short-form 36 quality-of-life questionnaire; WHO-5, World Health Organization 5-item questionnaire.
Note: Difference refers to changes of 12-month value minus baseline value. Positive differences indicate advantages of remote telemonitoring.